We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Novel genotypes and phenotypes among Chinese patients with Floating-Harbor syndrome.
- Authors
Zhang, Shujie; Chen, Shaoke; Qin, Haisong; Yuan, Haiming; Pi, Yalei; Yang, Yu; Huang, Hui; Li, Guimei; Sun, Yan; Wang, Zhihua; Ma, Huamei; Fu, Xiaoling; Zhou, Ting; Wang, Jian; Zhang, Huifeng; Shen, Yiping
- Abstract
<bold>Background: </bold>Floating-Harbor syndrome (FHS) is a rare syndromic short stature disorder caused by truncating variants in SRCAP. Few Chinese FHS patients had been reported so far and limited knowledge regarding the benefit of growth hormone treatment existed.<bold>Methods: </bold>We ascertained 12 short stature patients with molecularly confirmed diagnosis of FHS by whole exome sequencing. We performed a comprehensive clinical evaluation for all patients and assessed the responsiveness of growth hormone treatment in a subset of the patients.<bold>Results: </bold>Five distinct pathogenic/likely pathogenic variants were identified in 12 independent FHS patients including two previously reported variants (c.7303C > T/p.Arg2435Ter and c.7330C > T/p.Arg2444Ter) and three novel variants (c.7189G > T/p.Glu2397Ter, c.7245_7246delAT/p.Ser2416ArgfsTer26 and c.7466C > G/p.Ser2489Ter). The c.7303C > T/p.Arg2435Ter mutation appears more common in Chinese FHS patients. The clinical presentations of Chinese FHS patients are very similar to those of previously reported patients of different ethnicities. Yet we noticed micropenis and ear abnormalities in multiple patients, suggesting that these may be novel phenotypes of Floating-Harbor syndrome. Eight patients (one with GH deficiency, one with undetermined GH level, six without GH deficiency) underwent growth hormone treatment, 3 patients had good responses, one with modest and two with poor responses.<bold>Conclusion: </bold>We described novel genotypes and phenotypes in a Chinese FHS patient cohort. We showed that about half of FHS patients exhibited modest to good response to GH treatment regardless of their respective GH deficiency status. We didn't find any correlation between different mutations and response to GH treatment.
- Subjects
SOMATOTROPIN; SHORT stature; GENOTYPES; PITUITARY dwarfism
- Publication
Orphanet Journal of Rare Diseases, 2019, Vol 14, Issue 1, pN.PAG
- ISSN
1750-1172
- Publication type
journal article
- DOI
10.1186/s13023-019-1111-8